NuPathe Terminates Agreement With Endo Pharma and Enters Into Agreement to Be Acquired by Teva

NuPathe (NASDAQ: PATH ) today announced that it has terminated its agreement and plan of merger with Endo Health Solutions Inc. and its Board has withdrawn its recommendation that stockholders accept Endo's offer to acquire all outstanding shares of NuPathe common stock. NuPathe has also entered into an